ArticleFrontiers in oncology2022

Identified Gefitinib Metabolism-Related lncRNAs can be Applied to Predict Prognosis, Tumor Microenvironment, and Drug Sensitivity in Non-Small Cell Lung Cancer.

Weilong Ye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.